F. Bert
Impact in
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
- Endocrinology top 2%
Papers in
-
- Antibiotic Resistance in Bacteria 12
-
- Antimicrobial Resistance in Staphylococcus 5
- Co-authors
- N Lambert-Zechovsky (17 shared papers)Catherine Branger (6 shared papers)B. Bruneau (2 shared papers)P J Berry (1 shared paper)Richard Moreau (5 shared papers)François Durand (5 shared papers)Jacques Belghiti (5 shared papers)M.‐H. Nicolas‐Chanoine (7 shared papers)
- Journals
- European Journal of Clinical Microbiology & Infectious Diseases (3 papers)Journal of Clinical Microbiology (2 papers)Journal of Medical Microbiology (2 papers)Journal of Antimicrobial Chemotherapy (2 papers)Clinical Infectious Diseases (1 paper)
- Partner nations
- FranceUnited StatesEgypt
In The Last Decade
F. Bert
26 papers receiving 883 citations
Peers
Comparison fields: 5 of 89
- Molecular Medicine 391
- Endocrinology 222
- Applied Microbiology and Biotechnology 86
- Critical Care and Intensive Care Medicine 119
- Clinical Biochemistry 89
Countries citing papers authored by F. Bert
This map shows the geographic impact of F. Bert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Bert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Bert more than expected).
Fields of papers citing papers by F. Bert
This network shows the impact of papers produced by F. Bert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Bert. The network helps show where F. Bert may publish in the future.
Co-authors
The 25 scholars most cited alongside F. Bert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 148 | |
| 2 | 2002 | 138 | |
| 3 | 2012 | 126 | |
| 4 | 1997 | 64 | |
| 5 | 2000 | 56 | |
| 6 | 2003 | 48 | |
| 7 | 1997 | 47 | |
| 8 | 1995 | 42 | |
| 9 | 1996 | 41 | |
| 10 | 2013 | 35 | |
| 11 | 2010 | 30 | |
| 12 | 2008 | 21 | |
| 13 | 1997 | 15 | |
| 14 | [Epidemiological studies of the susceptibility of Pseudomonas aeruginosa to antibiotics]. | 1994 | 15 |
| 15 | 2014 | 14 | |
| 16 | 1996 | 14 | |
| 17 | 2012 | 14 | |
| 18 | 2007 | 13 | |
| 19 | 2011 | 10 | |
| 20 | 2008 | 9 |
About F. Bert
F. Bert is a scholar working on Molecular Medicine, Infectious Diseases, Epidemiology, Clinical Biochemistry and Pharmacology, having authored 27 papers that have together received 930 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (12 papers), Bacterial Identification and Susceptibility Testing (8 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers), Streptococcal Infections and Treatments (6 papers), Antimicrobial Resistance in Staphylococcus (5 papers), Antibiotic Use and Resistance (5 papers), Nosocomial Infections in ICU (4 papers) and Escherichia coli research studies (3 papers). The work is most often cited by research in Molecular Medicine (391 citations), Endocrinology (222 citations), Applied Microbiology and Biotechnology (86 citations), Critical Care and Intensive Care Medicine (119 citations) and Clinical Biochemistry (89 citations). F. Bert has collaborated with scholars based in France, United States and Egypt. Frequent co-authors include N Lambert-Zechovsky, Catherine Branger, B. Bruneau, P J Berry, Richard Moreau, François Durand, Jacques Belghiti, M.‐H. Nicolas‐Chanoine, Véronique Leflon‐Guibout and Jacques‐Olivier Galdbart. Their work appears in journals such as European Journal of Clinical Microbiology & Infectious Diseases, Journal of Clinical Microbiology, Journal of Medical Microbiology, Journal of Antimicrobial Chemotherapy and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.